$18.20
1.24 (+7.31%)
Incyte Corp (NASDAQ:INCY)
CAPS Rating:
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.